Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-016053
Filing Date
2024-06-07
Accepted
2024-06-07 18:00:07
Documents
1
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 form4-06072024_060604.html 4  
1 form4-06072024_060604.xml 4 4096
  Complete submission text file 0001415889-24-016053.txt   5549
Mailing Address C/O ACCELERON PHARMA INC. 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Dable Habib J (Reporting) CIK: 0001690773 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40544 | Film No.: 241030934

Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Issuer) CIK: 0001798749 (see all company filings)

IRS No.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)